This video features a discussion between Dr. Elias Bjornson, a heart disease researcher, and Gil, the host, about remnant lipoproteins and their atherogenicity compared to LDL. They explain what lipoproteins are, categorize atherogenic lipoproteins, and delve into the methodology and findings of research comparing the risk posed by remnant particles versus LDL particles. The discussion also touches upon residual risk, methods for calculating remnant cholesterol, and the clinical implications of these findings.
